Overview and Chemical Identity

3-(1H-Imidazol-5-yl)-2-(1H-pyrrol-1-yl)propanoic acid (Aladdin catalog number H1354859) is a bifunctional heterocyclic compound that combines the pharmacophoric properties of an imidazole ring — well known for its role in histidine residues and metal coordination — with a pyrrole ring, an aromatic nitrogen-containing system prevalent in natural products and drug candidates. The molecule also bears a propanoic acid backbone, conferring zwitterionic character under physiological pH conditions analogous to histidine derivatives.

The compound is of interest as a non-natural amino acid analog and synthetic intermediate, enabling researchers to introduce dual-ring heterocyclic motifs into peptides, small molecules, and macrocyclic frameworks. Its unique combination of ring systems makes it suitable for probing biological targets that recognise imidazole or pyrrole pharmacophores.

Materials and Safety Precautions

Materials required:

• 3-(1H-Imidazol-5-yl)-2-(1H-pyrrol-1-yl)propanoic acid (H1354859, Aladdin Scientific)
• Analytical balance (±0.01 mg sensitivity)
• Appropriate solvents: anhydrous DMSO (for stock solutions), aqueous phosphate buffer (pH 6–8), or other polar solvents as required
• Amber glass vials or polypropylene microtubes for storage
• Personal protective equipment: lab coat, nitrile gloves, safety goggles

Safety precautions: As with all research chemicals, handle 3-(1H-Imidazol-5-yl)-2-(1H-pyrrol-1-yl)propanoic acid in a well-ventilated fume hood. Consult the product Safety Data Sheet (SDS) before use. The compound contains a free carboxylic acid moiety; avoid contact with skin and eyes. Dispose of waste in accordance with local institutional and regulatory guidelines.

Step-by-Step Handling and Dissolution Protocol

Step 1 – Equilibration: Remove the vial from cold storage and allow it to equilibrate to room temperature (approximately 15–30 minutes) before opening, to prevent moisture condensation on the compound.

Step 2 – Weighing: Tare an amber glass vial or polypropylene microtube on the analytical balance. Using a clean, dry spatula, transfer the required mass of 3-(1H-Imidazol-5-yl)-2-(1H-pyrrol-1-yl)propanoic acid. Minimise exposure time to ambient air.

Step 3 – Stock solution preparation (DMSO): Add anhydrous DMSO to the weighed compound to achieve the desired concentration (e.g., 10–100 mM). Vortex gently for 30–60 seconds and sonicate briefly (5–10 minutes in a bath sonicator at room temperature) if full dissolution is not immediately observed. Visual clarity should be confirmed before use.

Step 4 – Aqueous dilution: If an aqueous working solution is required, dilute the DMSO stock into the appropriate aqueous buffer (e.g., PBS, pH 7.4). Keep the final DMSO content ≤1% v/v to minimise solvent effects on biological assays. Check for precipitation; if cloudiness occurs, adjust pH or use a co-solvent system.

Step 5 – Filtration (optional): For cell-based or biochemical assays requiring sterile, particle-free solutions, pass the final solution through a 0.22 µm syringe filter into a sterile container.

Step 6 – Aliquoting: Divide stock solutions into single-use aliquots to avoid repeated freeze–thaw cycles, which may degrade the compound over time.

Storage, Stability, and Quality Control

Storage conditions: Store 3-(1H-Imidazol-5-yl)-2-(1H-pyrrol-1-yl)propanoic acid as a solid in a cool, dry, dark environment. Refer to the specific storage temperature indicated on the product label and SDS (typically 2–8 °C or −20 °C for long-term storage). Always reseal the container tightly after use and consider storing under inert gas (argon or nitrogen) if the compound is moisture- or oxygen-sensitive.

Stability of solutions: DMSO stock solutions are generally more stable than aqueous solutions. Prepared stock solutions should be stored at −20 °C in sealed, light-protected vials. Aqueous solutions should be freshly prepared where possible or stored for the shortest practical duration.

Quality control checks: Before use in critical experiments, verify compound identity and purity by at least one analytical method, such as:

• TLC or HPLC (purity assessment)
• ¹H NMR (structural confirmation of imidazole and pyrrole proton signals)
• High-resolution mass spectrometry (exact mass confirmation)

Any discrepancy from the expected analytical profile should be reported to Aladdin Scientific for investigation.

Troubleshooting

Problem: Compound does not dissolve completely in DMSO.
Solution: Warm the vial gently to 37–40 °C in a water bath and vortex again. Do not heat above 60 °C. If precipitation persists, try an alternative solvent such as methanol or dilute aqueous base (e.g., 0.1 M NaHCO₃), considering that the carboxylic acid will ionise under basic conditions to improve solubility.

Problem: Precipitation upon aqueous dilution.
Solution: Reduce the DMSO stock concentration before dilution, pre-warm the aqueous buffer, or use a more hydrophilic buffer system. Adjusting the pH toward 7–8 may improve solubility by ionising the carboxylic acid.

Problem: Colour change or browning of solution.
Solution: Discard the solution and prepare fresh. Discolouration may indicate oxidative degradation of the pyrrole ring system. Minimise exposure to light and dissolved oxygen by using amber vials and degassed solvents.

Problem: Unexpected results in biological assay.
Solution: Re-confirm compound purity by HPLC. Check that DMSO concentration in the assay is within acceptable limits. Prepare a fresh stock solution and repeat the assay.